Blog single – Ibere Pharmaceuticals

Welcome to Ibere Pharmaceuticals

Home
Our Team
Investors
News
Contact

Recent Posts

April 19, 2021
Ibere Pharmaceuticals Announces the Separate Trading of its Class A Ordinary Shares and Redeemable Warrants Commencing April 19, 2021
March 2, 2021
Ibere Pharmaceuticals Announces Closing of $138,000,000 Initial Public Offering
March 1, 2021
Philadelphia-based blank check company Ibere Pharmaceuticals completes $120M IPO

About Ibere

Providing New Beginnings to Branded Pharmaceutical Portfolios with a Focus on Margin Improvement and Global Market Growth.

Subscribe Today

Subscribe to our newsletter.

Δ

Contact Ibere

If you have any questions or comments please feel free to contact us using one of the links below:

+ 1 (267) 765-3235

www.iberepharma.com

info@iberepharma.com

Ibere Pharmaceuticals © 2021. All rights reserved.

Homepage
Our Team
Investors
News
Contact